Eleven Biotherapeutics, Inc.

Robbins Arroyo LLP Is Investigating the Officers and Directors of Eleven Biotherapeutics, Inc. (EBIO) on Behalf of Shareholders

Robbins Arroyo LLP is investigating whether certain officers and directors of Eleven Biotherapeutics, Inc. (NASDAQGM: EBIO) breached their fiduciary duties to shareholders. Eleven Biotherapeutics is a clinical-stage biopharmaceutical company that engages in the discovery and development of protein therapeutics to treat eye diseases, primarily in the United States.

Eleven Biotherapeutics Fails Drug Trial

On May 18, 2015, Eleven Biotherapeutics announced that its lead drug candidate, EBI-005, designed to treat moderate to severe dry eye disease, failed to meet its primary endpoints in a late stage trial. Specifically, the company revealed that there was no statistically significant difference between those taking EBI-005 and the control group. As a result, Eleven Biotherapeutics said that it will not pursue a second Phase 3 trial of the drug for dry eye disease. On this news, shares of Eleven Biotherapeutics experienced a one day decline of $8.29 per share, or over 69%, to close at $3.69 per share on May 18, 2015.

In light of this news, Robbins Arroyo LLP’s investigation focuses on whether Eleven Biotherapeutics and/or its officers mislead shareholders by issuing false statements regarding the company’s drug and business prospects that improperly inflated the company’s stock price.

Eleven Biotherapeutics Shareholders Have Legal Options

Concerned shareholders who would like more information about their rights and potential remedies can contact attorney Darnell R. Donahue at (800) 350-6003, or you can complete the form below and we will contact you directly.

 

Shareholder Information

Items marked with an asterisk (*) are required information.

First Name * Last Name *
Address City State/Province *
ZIP/Postal Code Country/Region Phone *
E-mail * Confirm: E-mail *

Shares Purchased:
Number of Shares: Buy Date : Price Per Share:
example: 125 example: MM/DD/YYYY example: 30.00
transaction:
transaction:
transaction:
transaction:
transaction:
If you have additional transactions or comments, please input the information below:

Shares Sold:
Number of Shares: Sell Date : Price Per Share:
example: 125 example: MM/DD/YYYY example: 30.00
transaction:
transaction:
transaction:
transaction:
transaction:
If you have additional transactions or comments, please input the information below:

Please Note: Neither the submission to nor the receipt of information by Robbins Arroyo LLP or one of its attorneys through this website constitutes an agreement by our firm to represent the individual and does not create an attorney-client relationship. Please do not send confidential or sensitive information through this website. This information should be communicated through a direct contact with an individual at the firm.

* I have read the disclaimer information
+=

    Send This Post

    Tags: